Synthesis and biological evaluation of Chromenylurea and Chromanylurea derivatives as anti-TNF-α agents that target the p38 MAPK pathway.
Molecules
; 19(2): 2004-28, 2014 Feb 13.
Article
en En
| MEDLINE
| ID: mdl-24531217
ABSTRACT
A series of 1-aryl-3-(2H-chromen-5-yl)urea and 1-aryl-3-(chroman-5-yl)urea derivatives were designed, synthesized and evaluated for their inhibitory activities towards TNF-α production in lipopolysaccharide-stimulated THP-1 cells. The most active compound, 40g, inhibited TNF-α release with an IC50 value of 0.033 µM, which is equipotent to that of BIRB796 (IC50 = 0.032 µM).
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Urea
/
Benzopiranos
/
Factor de Necrosis Tumoral alfa
Límite:
Humans
Idioma:
En
Revista:
Molecules
Asunto de la revista:
BIOLOGIA
Año:
2014
Tipo del documento:
Article
País de afiliación:
China